Results for this period
Full year1 April 2025–31 March 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In addition to the absence of the contract upfront payment recorded in the previous fiscal year in connection with a large out-licensing agreement, the Company continued to invest in research and development during the fiscal year under review.
Material events, etc. are described. The Company recorded a material operating loss for the fiscal year under review, and events or conditions exist that raise substantial doubt about the going concern assumption. However, the Company determined that no material uncertainty exists. There are no applicable notes regarding the going concern assumption.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥200 million (YoY -85.3%) |
| Operating profit | ¥-787 million |
| Ordinary income | ¥-760 million |
| Profit attributable to owners of the parent | ¥-761 million |
| Net income per share | -¥29.58 |
| Operating Margin | △393.9% |
| Equity ratio | End of the current fiscal period 65.5 / End of previous period 63.4 |
| Total assets | ¥1,318 million |
| Net assets | ¥863 million |
| Cash flows from operating activities | ¥-577 million |
| Cash flows from investing activities | ¥-8 million |
| Cash flows from financing activities | ¥17 million |
| Cash and cash equivalents at end of period | ¥969 million |
| Full-year earnings forecast | Net Sales Forecast value 1,100～1,500 / Year-on-year change 549.9～749.9% / Operating profit Forecast value 5～50 / Year-on-year change Not disclosed / Ordinary income Forecast value 45～90 / Year-on-year change Not disclosed / Net income Forecast value 45～90 / Year-on-year change Not disclosed |
| Annual Dividend Forecast | ¥0.00 → ¥0.00 |
| Depreciation and amortization | ¥20,993 thousand |
| Breakdown of extraordinary income (loss) | Gain on sale of non-current assets ¥58 thousand, No recognition － |
| Disclosure regarding the going concern assumption | Material events, etc. are described. The Company recorded a material operating loss for the fiscal year under review, and events or conditions exist that raise substantial doubt about the going concern assumption. However, the Company determined that no material uncertainty exists. There are no applicable notes regarding the going concern assumption. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 25,794,300 shares |
| Treasury Shares at Period-End | 0 shares |
| Factors Behind Changes in Business Performance | In addition to the absence of the contract upfront payment recorded in the previous fiscal year in connection with a large out-licensing agreement, the Company continued to invest in research and development during the fiscal year under review. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was due to the absence of the contract upfront payment recorded in the previous fiscal year in connection with a large out-licensing agreement, as well as the continued investment in research and development during the fiscal year under review.